Latest BayBio Stories

SAN FRANCISCO and SAN DIEGO, Oct. 1, 2012 /PRNewswire/ -- BayBio and BIOCOM, the trade associations for the Northern and Southern California life science clusters respectively, today thanked Governor Jerry Brown and Assemblyman Jerry Hill (D-San Mateo) upon the signing of his AB 1277, legislation which addresses facility inspections by state regulators that are largely duplicative of those already done by the US Food and Drug Administration (FDA). AB 1277 will eliminate many of those...

SAN FRANCISCO, March 7, 2012 /PRNewswire/ -- More than 1,100 leaders from across California's life sciences industry will converge on San Francisco for the two-day conference CALBIO2012: Driven by Patients on March 8-9. The conference focus is to increase patient access to new treatments through partnering and collaborative research. For the first time, BayBio and BIOCOM are organizing a statewide meeting for California's life sciences companies. CALBIO2012: Driven by Patients will...

SACRAMENTO, Calif., Feb. 8, 2012 /PRNewswire/ -- After two decades of steady annual job growth, employment in California's biomedical industry stalled while the state has struggled to recover from financial shortfalls and the industry adapts to a sharp pullback in funding from risk-averse investors in an uncertain regulatory environment, according to the 2012 California Biomedical Industry Report published today by the California Healthcare Institute, BayBio and PwC US. (Logo:...

SAUSALITO, Calif., Jan. 24, 2012 /PRNewswire/ -- Sanovas CEO Larry Gerrans will participate in a panel titled "Fundraising in Troubled Times" as part of BayBio's Life Sciences Series on Thursday, Jan. 26 at 8 a.m. in Palo Alto. The event will take place at the Silicon Valley offices of DLA Piper. Gerrans will speak about alternative approaches to funding and the emerging trends and opportunities in business financing, including the proposed legislative changes to the laws that...

SAN FRANCISCO, Jan. 10, 2012 /PRNewswire/ -- Access to capital, a burdensome and uncertain regulatory environment and lack of innovation and productivity in research and development are the biggest threats to the biomedical industry's growth over the next five years, according to biomedical company CEOs surveyed by CHI-California Healthcare Institute, BayBio and PwC US. The CEO Survey found: Nearly three quarters (74 percent) of biomedical industry CEOs surveyed said their companies...

SAN FRANCISCO, Jan. 9, 2012 EVENT: Live Press Briefing on Findings of Biomedical Industry CEO Survey WHEN: Tuesday, Jan. 10, 2012 TIME: 10 a.m. - 10:45 a.m. PT presentation and Q&A WHO: --CEOs from three biotechnology companies: NuVasive (NASDAQ: NUVA), Omniox and...

SOUTH SAN FRANCISCO, Calif., Oct. 5, 2011 /PRNewswire/ -- A recent survey of California's pioneering industrial biotechnology sector shows that this sector has great potential for job growth in the state. California's industrial biotechnology industry increased employment by 632 percent in the past five years, according to a survey conducted by BayBio and BIOCOM, the leading biotechnology industry associations in the state, and Radford, a compensation consulting firm. California's...

SACRAMENTO, Calif., Feb. 1, 2011 /PRNewswire/ -- Eighty percent of biomedical company CEOs in California report that their companies have been courted by other countries, state governments or regional economic development associations in the past year, according to survey findings included in the 2011 California Biomedical Industry Report, published today by the California Healthcare Institute, BayBio and PwC. Yet the survey found surprising consensus of confidence in the state's ongoing...

SACRAMENTO, Calif., Jan. 26, 2011 /PRNewswire/ -- Live Media Webcast to present findings of 2011 California EVENT: Biomedical Industry Report WHEN: Tuesday, Feb. 1, 2011 9:00 a.m. - 9:45 a.m. PT /12:00 p.m. - 12:45 p.m. ET TIME: presentation and Q&A -- David Gollaher, Ph.D., CEO, California Healthcare WHO: Institute -- Tracy Lefteroff, National Life Sciences partner, PwC US...

BayBio, which represents Northern California's life sciences industry, today announced support for California's Algebra I exam as California's test to measure eighth-grade mathematics for federal accountability purposes. "As the oldest, largest and most productive life sciences cluster in the world, the industry is based on a math and science foundation," said Matthew M. Gardner, president and CEO of BayBio. "Algebra is the gateway to critical thinking, pivotal for success in science,...